Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Nuokang Bio-Pharma Given Board OK to Go Private

publication date: Sep 27, 2012
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China Nuokang Bio-Pharma has accepted a go-private offer of $5.80 per ADS that values the company at $114 million. The offer comes from Yuhuan Zhu, the wife of the company's chairman/CEO, along with Grand Enterprises Group Co., Ltd., which will own 55% of the company post-transaction. Grand Enterprise is a China investment company. Nuokang’s Board has recommended that shareholders vote in favor of accepting the offer. More details....

Stock Symbol: (NSDQ: NKBP)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners